The beneficial effect of donor-specific transfusions: A review of existing explanations and a new hypothesis based on a relatively unapplied theory of T cell immunoregeneration. A regulatory hypothesis in progress...

Medical Hypotheses

Volumn 54, Issue 6, 2000, Pages 922-943

  Wendel, T D ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD TRANSFUSION; HISTOCOMPATIBILITY; HUMAN; IMMUNE SYSTEM; IMMUNOREGULATION; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; SUPPRESSOR CELL; T LYMPHOCYTE;

EID: 0033922186     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1999.0989     Document Type: Article

References (130)

1. Salvatierra O. Jr, Vincenti F., Amend W. Deliberate donor-specific blood transfusions prior to living related renal transplantation. Ann Surg. 192:1980;543.
2. Sollinger H. W., Cook K., Sparks E. M. Donor-specific transfusions in one-haplotype mismatched high MLC donor-recipient combinations and in vitro analysis. Transplant Proc. 15:1983;935.
3. Leivestad T., Thorsby E. Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness. Transplantation. 37:1984;175.
4. Hillis A. N., Duguid J., Evans C. M., Bone J. M., Sells R. A. Three year experience of donor specific transfusion and concomitant cyclosporin A. Transplant Proc. 19:1987;2248.
5. Matsumoto T., Sakagami K., Orita K. Role of donor specific blood transfusions in prolongation of kidney graft survival. Transplant Proc. 19:1987;2264.
6. Anderson C. B., Sicard G. A., Etheredge E. E. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products. Surgery. 92:1982;315.
7. Whelchel J. D., Shaw J. F., Curtis J. J., Luke R. G., Diethelm A. G. Effect of pretransplant stored donor-specific blood transfusions on early renal allograft survival in one-haplotype living related transplants. Transplantation. 34:1982;326.
8. Norman D. J., Henell K., Fletcher L., Barry J. Donor specific transfusions: a five-year experience with alternative protocols. Transplant Proc. 19:1987;2252.
9. Light J. A., Metz S. J., Oddenino K. Donor-specific transfusion with minimal sensitization. Transplant Proc. 15:1983;917.
10. Burlingham W. J., Sollinger H. W. Action of donor-specific transfusions - analysis of three possible mechanisms. Transplant Proc. 18:1986;685.
11. Opelz G., Persijn G. G. Blood transfusion in renal transplantation. Transplant Proc. 13:1981;1685.
12. Norman D. J., Wetzsteon P., Barry J. M., Fischer S. Blood transfusions are beneficial in HLA-identical sibling kidney transplants. Transplant Proc. 17:1985;2347.
13. Sollinger H. W., Kalayoglu M., Belzer F. O. Use of the donor specific transfusion protocol in living-unrelated donor-recipient combinations. Ann Surg. 204:1986;315.
14. Salvatierra O. Jr, Melzer J., Potter D. A seven year experience with donor-specific blood transfusions. Results and considerations for maximum efficiency. Transplantation. 40:1985;654.
15. Terasaki P. I. The beneficial transfusion effect on kidney graft survival attributed to clonal deletion. Transplantation. 37:1984;119.
16. Green D. R., Flood P. M., Gershon R. K. Immunoregulatory T-cell pathways. Ann Rev Immunol. 1:1983;439.
17. Heijnen C. J., Pot K. H., Ballieux R. E. Characterization of human T suppressor-inducer, -precursor and -effector lymphocytes in the antigen-specific plaque-forming cell response. Eur J Immunol. 12:1982;860.
18. Dorf M. E., Benacerraf B. Suppressor cells and immunoregulation. Ann Rev Immunol. 2:1984;127.
19. Sumida T., Takei I., Taniguchi M. Activation of acceptor-suppressor hybridoma with antigen-specific suppressor T cell factor of two chain type: requirement of the antigen- and the I-J restricting specificity. J Immunol. 133:1984;1131.
20. Zembala M. A., Asherson G. L., James B. M. B., Stein V. E., Watkins M. C. Anti-haptene T suppressor factor acts through an I-J+, Ly 1-2+, T acceptor cell that releases a nonspecific inhibitor of the transfer of contact sensitivity when exposed to antigen. J Immunol. 129:1982;1823.
21. Yamauchi K., Murphy D., Cantor H., Gershon R. K. Analysis of antigen-specific, Ig-restricted cell-free material made by I-J+ Ly-1 cells (Ly-1 TsiF) that induces Ly-2+ cells to express suppressive activity. Eur J Immunol. 11:1981;905.
22. Flood P., Yamauchi K., Singer A., Gershon R. K. Homologies between cell interaction molecules controlled by major histocompatibility complex- and Igh-V-linked genes that T cells use for communication. Tandem "adaptive" differentiation of producer and acceptor cells. J Exp Med. 156:1982;1390.
23. Usui M., Aoki I., Sunshine G. H., Dorf M. E. A role for macrophages in suppressor cell induction. J Immunol. 132:1984;1728.
24. Aoki I., Minami M., Dorf M. E. A mechanism responsible for the induction of H-2 restricted second order suppressor T cells. J Exp Med. 157:1983;1726.
25. Green D. R., Eardley D. D., Kimura A., Murphy D. B., Yamauchi K., Gershon R. K. Immunoregulatory circuits which modulate responsiveness to suppressor cell signals: characterization of an effector cell in the contrasuppressor circuit. Eur J Immunol. 11:1981;973.
26. Yamauchi K., Taniguchi M., Green D., Gershon R. K. The use of a monoclonal I-J-specific antibody to distinguish cells in the feedback suppression circuit from those in the contrasuppressor circuit. Immunogenetics. 16:1982;551.
27. Gershon R. K., Eardley D. D., Durum S. Contrasuppression. A novel immunoregulatory activity. J Exp Med. 153:1981;1533.
28. Green D. R., Gershon R. K. Contrasuppression: the second law of thymodynamics, revisited. Adv Canc Res. 42:1984;277.
29. Tada T., Okumura K. The role of antigen-specific T cell factors in the immune response. Adv Immunol. 28:1979;1.
30. Katz D. R., Feldmann M., Tees R., Schreier M. H. Heterogeneity of accessory cells interacting with T-helper clones. Immunology. 58:1986;167.
31. Usui M., Aoki I., Sunshine G. H., Dorf M. E. Requirements for suppressor T cell activation. J Immunol. 133:1984;1137.
32. Golding H., Singer A. Role of accessory cell processing and presentation of shed H-2 alloantigens in allospecific cytotoxic T lymphocyte responses. J Immunol. 133:1984;597.
33. Krowka J. F., Shiozawa C., Diener E., Pilarski L. M. Functional activity of soluble antigen-specific helper T cell molecules. Requirement for separable entities for the induction of cytotoxic T cell and B cell responses. Transplantation. 42:1986;162.
34. Maurer D. H., Collins W. E., Hanke J. H., Van M., Rich R. R., Pollack M. S. Class II positive human dermal fibroblasts restimulate cloned allospecific T cells but fail to stimulate primary allogeneic lymphoproliferation. Hum Immunol. 14:1985;245.
35. Flood P. M., Janeway C. A. Jr, Gershon R. K. B cell deprived mice lack functional expression of certain T suppressor cell subsets. J Mol Cell Immunol. 1:1984;167.
36. Aprile J., Deeg H. J. Ultraviolet irradiation of canine dendritic cells prevents mitogen-induced cluster formation and lymphocyte proliferation. Transplantation. 42:1986;653.
37. Steinman R. M., Nussenzweig M. C. Dendritic cells: features and functions. Immunol Rev. 53:1980;127.
38. Mason D. W., Pugh C. W., Webb M. The rat mixed lymphocyte reaction: roles of a dendritic cell in intestinal lymph and T-cell subsets defined by monoclonal antibodies. Immunology. 44:1981;75.
39. Klinkert W. E. F., LaBadie J. H., Bower W. E. Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues. J Exp Med. 156:1982;1.
40. Light J. A., Metz S., Oddenino K. Donor-specific transfusions with diminished sensitization. Transplantation. 34:1982;352.
41. Martinelli G. P., Horowitz C., Chiang K., Racelis D., Schanzer H. Pretransplant conditioning with donor-specific transfusions using heated blood and cyclosporine. Preservation of the transfusion effect in the absence of sensitization. Transplantation. 43:1987;140.
42. Malik S. T. A., Cahn P. S. F., El-Malik F. Potentiation of the transfusion effect by prior ultraviolet irradiation and heating of donor blood in a rat renal allograft model: evidence for dendritic cells as the primary sensitizing cell type. Transplant Proc. 17:1985;1131.
43. Baird M. A., Bradley M. P., Heslop B. F. Prolonged survival of cardiac allografts in rats following the administration of heat-treated donor lymphocytes. A possible immunosuppressive role for class I major histocompatibility complex antigens. Transplantation. 42:1986;1.
44. Heineman E., Bouwman E., de Bruin R. W. F., Marquet R. L., Jeekel J. The role of passenger leukocytes in the manifestation of the donor-specific transfusion phenomenon. Transplant Proc. 17:1985;821.
45. Fox I. J., Sy M-S., Benacerraf B., Greene M. I. Impairment of antigen-presenting cell function by ultraviolet radiation II. Effect on in vitro ultraviolet irradiation on antigen-presenting cells. Transplantation. 31:1981;262.
46. Kapsenberg M. L., Teunissen M. B. M., Stiekema F. E. M., Keizer H. G. Antigen-presenting cell function of dendritic cells and macrophages in proliferative T cell responses to soluble and particulate antigens. Eur J Immunol. 16:1986;345.
47. Miyazaki H., Osawa T. Accessory functions and mutual cooperation of murine macrophages and dendritic cells. Eur J Immunol. 13:1983;984.
48. Inaba K., Steinman R. M. Antibody responses to T-dependent antigens: contributions of dendritic cells and helper T lymphocytes. Adv Exp Med Biol. 186:1985;369.
49. Inaba K., Witmer M. D., Steinmen R. M. The clustering of dendritic cells, helper T lymphocytes and histocompatible B cells during primary antibody responses in vitro. J Exp Med. 160:1984;858.
50. Inaba K., Steinman R. M. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine releases. J Exp Med. 160:1984;1717.
51. Powderly N. G., Schreiber J. R., Pier G. B., Markham R. B. T cells recognizing polysaccharide-specific B cells function as contrasuppressor cells in the generation of T cell immunity to pseudomonas aeruginosa. J Immunol. 140:1988;2746.
52. Yamauchi K., Green D. R., Eardley D. D., Murphy D. B., Gershon R. K. Immunoregulatory circuits that modulate responsiveness to suppressor cell signals. Failure of B10 mice to respond to suppressor factors can be overcome by quenching the contrasuppressor circuit. J Exp Med. 153:1981;1547.
53. ksuppressor factors in (nonsuppressor x nonsuppressor) F1 mice. J Exp Med. 155:1982;955.
54. Benacerraf B. Role of MHC gene products in immune regulation. Science. 212:1981;1229.
55. Ptak W., Rozycka D., Askenase P. W., Gershon R. K. Role of antigen-presenting cells in the development and persistence of contact hypersensitivity. J Exp Med. 151:1980;362.
56. Loblay R. H., Pritchard-Briscoe H., Basten A. Suppressor T-cell memory. Nature. 272:1978;620.
57. Bril H., DeRuiter H., Hussarts-Odijk L. M., Bianchi A. T. J., Benner R. Suppression of antigraft immunity by preimmunization IV. Persistence by long-lived recirculating suppressor T cells. Transplantation. 40:1985;417.
58. Hall B. M., Dorsch S., Roser B. The cellular basis of allograft rejection in vivo II. The nature of memory cells in mediating second set heart graft rejection. J Exp Med. 148:1978;890.
59. Siegel J. P., Lane H. C., Stocks N. I., Quinnan G. V. Jr, Fauci A. S. Pharmacokinetics of lymphocyte-derived and recombinant DNA-derived interleukin-2 after intravenous administration to patients with the acquired immunodeficiency syndrome. J Biol Resp Mod. 4:1985;596.
60. Hanto D. W., Widmer M. B., Simmons R. L. Mediation of cellular recruitment in vivo by functionally distinct T cell clones. Transplantation. 42:1986;168.
61. Kupiec-Weglinski J. W., DeSousa M., Tilney N. L. The importance of lymphocyte migration patterns in experimental organ transplantation. Transplantation. 40:1985;1.
62. Krohn P. L., Zuckerman A. The effect of splenectomy on the survival of skin homografts in rabbits and on the response to cortisone. Br J Exp Pathol. 35:1954;223.
63. Billingham R. E., Brent L., Medawar P. B. Quantitative studies on tissue transplantation immunity: II. The origin, strength, and duration of actively and adoptively acquired immunity. Proc R Soc Lond. B143:1954;58.
64. Halasz N. A., Orloff M. J., Hirose F. Increased survival of renal homografts in dogs after injection of graft donor blood. Transplantation. 2:1964;453.
65. Miller J. F. A. P., Marshall A. H. E., White R. G. The immunological significance of the thymus. Adv Immunol. 2:1962;111.
66. Richter M., Berry M., Barron P. Cells involved in the immune response XXXI. The role of the spleen in the primary and secondary immune responses in the normal adult outbred rabbit: the initial localization of memory cells to the spleen and their subsequent dissemination to the thymus and peripheral lymph nodes. Clin Immunol Immunopath. 38:1986;101.
67. Gaulton G. N., Scobie J. V., Rosenzweig M. HIV-1 and the thymus. AIDS. 11:1997;403.
68. Hall B. M., Dorsch S., Roser B. The cellular basis of allograft rejection in vivo I. The cellular requirements for first-set rejection of heart grafts. J Exp Med. 148:1978;878.
69. Ron Y., Sprent J. T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol. 128:1987;2848.
70. Gershon R. K., Lance E. M., Kondo K. Immunoregulatory role of spleen localizing thymocytes. J Immunol. 112:1974;546.
71. Macher E., Chase M. W. Studies on the sensitization of animals with simple chemical compounds XI. The fate of labeled picryl chloride and dinitrochlorobenzene after sensitizing injections. J Exp Med. 129:1967;81.
72. Martin D. C., Hewitt C. W., Dowdy S., Naudin V. L., Bejinez A. G. Transfer of the beneficial blood transfusion effect on rat renal allograft survival by spleen isografts. Transplantation. 37:1984;319.
73. Streilein J. W., Niederkorn J. Y. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med. 153:1981;1058.
74. Meyer J. D., Argyris B. F., Meyer J. A. Splenectomy, suppressor cell activity, and survival in tumor bearing rats. J Surg Res. 29:1980;527.
75. Sy M-S., Miller S. D., Kowach H. B., Claman H. N. A splenic requirement for the generation of suppressor T cells. J Immunol. 119:1977;2095.
76. Balshi J. D., Perloff L. J. Splenectomy and donor-specific blood transfusion in rat cardiac allografts. Transplantation. 41:1986;118.
77. Sterioff S., Marsh J. W., Moore S. B., Engen D. E., Zincke H., Frohnert P. P. Splenectomy prior to donor-specific transfusions with azathioprine is associated with low incidence of sensitization. Transplant Proc. 17:1985;2349.
78. Shofer F. S., London W. T., Lyons P. Adverse effect of splenectomy on the survival of patients with more than one kidney transplant. Transplantation. 42:1986;473.
79. Hart D. N. J., Fabre J. W. Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissues of rat heart and other tissues, but not the brain. J Exp Med. 153:1981;347.
80. Humphrey J. H., Sandaram V. Origin and turnover of follicular dendritic cells and marginal zone macrophages in the mouse spleen. Adv Exp Med Biol. 186:1985;167.
81. Nieuwenhaus P. B cell differentiation: B cell subsets and factors, organs or structures involved in B lymphocyte genesis. Adv Exp Med Biol. 186:1985;203.
82. Hayry P. Intragraft events in allograft destruction. Transplantation. 38:1984;1.
83. Pollak R., Blanchard J. M., Lazda V. A. The splenic microenvironment and self recognition as factors in allograft rejection in rats. A study using indium-111-labeled cells. Transplantation. 42:1986;528.
84. Shelby J., Wakely E., Corry R. J. Splenectomy abrogates the improved graft survival achieved by donor-specific transfusions. Transplant Proc. 17:1985;1083.
85. Wotherspoon J. S., Dorsch S. E. The mechanism of prolonged graft survival following removal of the regional lymph node. Transplantation. 42:1986;532.
86. Hall G. J. Studies of the cells in the afferent and efferent lymph of lymph nodes draining the site of skin homografts. J Exp Med. 125:1967;737.
87. Barker C. F., Billingham R. E. The role of regional lymphatics in the skin homograft response. Transplantation. 5:1967;962.
88. Hutchinson I. V. Suppressor T cells in allogeneic models. Transplantation. 41:1986;547.
89. 1-derived suppressor factor in controlling restriction specificity. J Exp Med. 158:1983;1428.
90. Lenhard V., Mytilineos J., Hansen B., Wingen A-M., Wonigeit K., Opelz G. Immunoregulation after blood transfusions in the rat model-anti-idiotypic antibodies or suppressor cells. Transplant Proc. 17:1985;2393.
91. Cranston D., Wood K. J., Morris P. J. Suppression of allograft rejection in the rat by normal, but not heat-inactivated or irradiated donor spleen cells. Transplant Proc. 17:1985;2421.
92. Wood K. J., Morris P. J. The blood transfusion effect: suppression of renal allograft rejection in the rat using purified blood components. Transplant Proc. 17:1985;2419.
93. Hibberd A. D., Scott L. J. Allogeneic platelets increase survival of rat renal allografts. Transplantation. 35:1983;622.
94. El-Malik F., Malik S. T. A., Varghese Z., Sweny P., Moorhead J. F. The enhancing and sensitizing effects of donor blood components, including dendritic cells, in a rat renal allograft model. Transplantation. 38:1984;213.
95. Leuchart W., Alkins B. J., Davies D. A. L. Only B lymphocytes induce active enhancement of rat cardiac allografts. Transplantation. 29:1980;259.
96. Whelchel J. D., Curtis J. J., Barger B. O., Luke R. G., Diethelm A. G. The effect of pretransplant stored donor-specific blood transfusion on renal allograft survival in one-haplotype living-related transplant recipients. Transplantation. 38:1984;654.
97. Sunday M. E., Stadecker M. J., Wright J. A., Aoki I., Dorf M. E. Induction of immune responses by shistosome granuloma macrophages. J Immunol. 130:1983;2413.
98. Moreno M. E., Kreisler M., Plaza J. J., Luque A. Donor-specific transfusion and kidney transplants: immunological monitoring during preparatory period and post-transplant follow-up. Transplant Proc. 17:1985;2370.
99. Matsumoto T., Sakagami K., Tsuboi K. Possible mechanism of donor-specific blood transfusions in prolongation of kidney graft survival. Transplant Proc. 17:1985;2401.
100. Cochrum K., Hanes D., Potter D. Improved graft survival following donor-specific blood transfusions. Transplant Proc. 13:1981;1657.
101. Burlingham W. J., Sparks-Mackety E. M. F., Glass N. R., Belzer F. O., Sondel P. M., Sollinger H. W. Induction of MLC-inhibitory antibodies by donor-specific transfusions plus azathioprine. Heterogeneity of patient responses. Transplant Proc. 17:1985;623.
102. Newton W. T., Anderson C. B. Planned preimmunization of renal allograft recipients. Surgery. 74:1973;430.
103. Martin D. C., Hewitt C. W., Osborne J. G. Enhanced kidney graft survival in rats by single or multiple blood transfusion(s) and various blood products. Transplant Proc. 14:1982;407.
104. Marquet R. L., Heystek G. A. Induction of suppressor cells by donor-specific blood transfusions and heart transplantations in rats. Transplantation. 31:1981;272.
105. Gorczynski R. M., Boulanger M., Lau C. T cell-derived factor alone or in combination with immunosuppressive drugs augments prolongation of allogeneic skin graft survival in mice receiving donor-specific transfusion. J Immunol. 138:1987;3197.
106. Sherr D. H., Cheung N-K. V., Heghinian K. M., Benacerraf B., Dorf M. E. Immune suppression in vivo with antigen-modified syngeneic cells. II, T cell-mediated nonresponsiveness to fowl Y globulin. J Immunol. 122:1979;1899.
107. Wood M. L., Gottschalk R., Monaco A. P. Comparison of immune responsiveness in mice after single or multiple donor-specific transfusions. J Immunol. 132:1984;651.
108. Werder A. A., Hardin C. A. A study of consecutively homografted skin on CFW mice. Surgery. 35:1954;371.
109. Zanker B., Kabelitz D., Herzog W. R., Franz H. E., Wagner H. The impact of uremia and renal transplantation on alloreactive cytotoxic T cell precursor (CTL-P) frequencies: quantitative assessment by limiting dilution analysis. Transplant Proc. 18:1986;1336.
110. Cohen D. J., Lee H. M., Mohanakumar T. Mechanisms of CML hyporesponsiveness in long-term renal allograft recipients. Hum Immunol. 14:1985;279.
111. Wood P. J., Strome P., Streilein J. W. Clonal frequency of alloreactive cells in mice tolerant of H-2. Transplant Proc. 17:1985;1137.
112. Mickleson E. M., Bean M. A., Ishioka S., Hansen J. A. Monitoring alloimmune responses in vivo following donor-specific transfusion: generation of suppressor T cells and alterations in alloreactive precursor frequencies. Transplant Proc. 17:1985;2389.
113. Stark R. B., Dwyer E. The enhancement of homografts of skin in the adult rabbit using elements of homologous whole blood. Surgery. 46:1959;277.
114. Medawar P. B., Billingham R. E., Sparrow E. M. Actively acquired tolerance. Transplant Bull. 3:1953;68.
115. Marquet R. L., Heystek G. A., Tinbergen W. J. Specific inhibition of organ allograft rejection by donor blood. Transplant Proc. 3:1971;708.
116. Jenkins A. McL., Woodruff M. F. A. The effect of prior administration of donor strain blood or blood constituents on the survival of cardiac allografts in rats. Transplantation. 12:1971;57.
117. Fabre J. W., Morris P. J. The effect of donor strain blood pretreatment on renal allograft rejection in rats. Transplantation. 14:1972;608.
118. Marquet R. L., Heystek G. A., Niessen G. J. C. M., Jeekel J. Induction of suppressor cells by a single blood transfusion in rats. Transplant Proc. 14:1982;394.
119. Opelz G. Blood transfusions and renal transplantation. Morris P. J. Kidney transplantation: Principles and practice. 1984;323 Grune & Stratton, London, New York, Orlando.
120. Hutchinson I. V., Morris P. J. The role of major and minor histocompatibility antigens in active enhancement of rat kidney allograft survival by blood transfusion. Transplantation. 41:1986;166.
121. Manca F., Barocci S., Kunkel A., Gurreri G., Costantini M., Celada F. Recognition of donor fibroblast antigens by lymphocytes homing in the human grafted kidney. Transplantation. 36:1983;670.
122. Pfeffer P. F., Thorsby E. HLA-restricted cytotoxicity against male-specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney. Transplantation. 33:1982;52.
123. Snider M. E., Armstrong L., Hudson J. L., Steinmuller D. In vitro and in vivo cytotoxicity of T cells cloned from rejecting allografts. Transplantation. 42:1986;171.
124. Burlingham W. J., Sparks-Mackety E. M. F., Pan M. H., Sondel P. M., Sollinger H. W. Beneficial effect of pretransplant donor-specific transfusions: evidence for an idiotype network mechanism. Transplant Proc. 17:1985;2376.
125. Damle N. K., Engleman E. G. Immunoregulatory T cell circuits in man. Alloantigen-primed inducer T cells activate alloantigen-specific suppressor T cells in the absence of the initial antigenic stimulus. J Exp Med. 158:1983;159.
126. Damle N. K., Mohagheghpour N., Engleman E. G. Activation of antigen-specific suppressor T lymphocytes in man involves dual recognition of self class I MHC molecules and Leu-4/T3-associated structures on the surface of inducer T lymphocytes. J Immunol. 133:1984;1235.
127. +-specific suppressor cells. J Immunol. 130:1983;785.
128. Toma H., Hayasaka Y., Tanabe K., Yasuo M., Ota K. Lymphocytotoxicity inhibition test to detect anti-idiotypic antibody in patients with donor-specific transfusions. Transplant Proc. 17:1985;2622.
129. Suzuki S., Mizuochi I., Sada M., Amemiya H. Transplantation tolerance mediated by suppressor T cells and suppressive antibody in a recipient of a renal transplant. Transplantation. 40:1985;357.
130. Lenhard V., Renner D., Hansen B., Opelz G. Suppression of antibody response and prolongation of skin graft survival by multiple blood transfusions in the rat. J Exp Med. 152:1980;2705.